The Ohio State University

The Ohio State University – Chemistry Graduate Studies is an educational sub-unit of The Ohio State University (the parent, a state-controlled 1862 land grant institution) operating as a non-profit organization and serving as a sub-recipient on federal research grants, with a sparse recent award footprint of eight total awards spanning two decades and concentrated in life sciences research.

Chemistry Graduate Studies operates exclusively as a sub-recipient on federal grants; it holds no prime federal contracts or contract vehicles, and five of its eight awards are prime grants held by the parent institution itself. The unit's three sub-grant awards represent recent activity: a March 2026 sub-award from the University of Tennessee for mitoprotective therapies research; a November 2025 sub-award from the University of Pittsburgh for reducing variation in access to medications for opioid use disorder under Medicaid; and a September 2025 sub-award from the University of Cincinnati for the Crane Center for Early Childhood Research and Policy. Combined potential value across all eight awards in the source data is $25 thousand, though combined dollars obligated total $1.4 million — a pattern indicating small-value awards with significant execution over time.

Federal customer concentration is fragmented across life sciences agencies. The Department of Health and Human Services National Institutes of Health (NIH) offices appear in three of the five top customers by award count: the National Heart Lung and Blood Institute, the National Institute of Diabetes and Digestive and Kidney Diseases, and the National Institute on Drug Abuse. The Department of Energy National Energy Technology Lab and the Department of Agriculture Forest Service Southern Research Station each anchor single awards. No customer agency dominates volume or potential value; the top five by count cover 63% of awards, and the top five by potential value cover only 41% of dollars, reflecting distributed engagement across multiple NIH institutes and other research funders.

Activity is episodic rather than continuous — one award in 2008, one in 2010, one in 2014, two in 2025, and one in 2026 — indicating ad-hoc participation in parent-institution research programs rather than standing capability or vehicle positioning. Chemistry Graduate Studies does not operate or bid independently; it functions as a research execution unit within the parent university's federal research enterprise.